The role of TGFβ in human cancers

Pathology

Volumn 33, Issue 1, 2001, Pages 85-92

  Wong, S F ^a   Lai, L C ^a  

^a Universiti Putra Malaysia   (Malaysia)

Author keywords

Carcinogenesis; Signal transduction pathway; Smad protein; TGF receptor; Transforming growth factor

Indexed keywords

GLYCAN; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; DNA BINDING PROTEIN; SMAD2 PROTEIN; SMAD2 PROTEIN, HUMAN; SMAD3 PROTEIN; SMAD3 PROTEIN, HUMAN; SMAD4 PROTEIN; SMAD4 PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN;

ARTICLE; CANCER; CARCINOGENESIS; CELL PROLIFERATION; EXTRACELLULAR MATRIX; GENE LOSS; HUMAN; INTRACELLULAR TRANSPORT; NONHUMAN; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; PROTEIN TRANSPORT; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION; CHEMISTRY; DOWN REGULATION; FEMALE; METABOLISM; NEOPLASM; PHYSIOLOGY; REVIEW;

DNA-BINDING PROTEINS; DOWN-REGULATION; FEMALE; HUMANS; NEOPLASMS; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SIGNAL TRANSDUCTION; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD4 PROTEIN; TRANS-ACTIVATORS; TRANSFORMING GROWTH FACTOR BETA;

EID: 0034745461     PISSN: 00313025     EISSN: None     Source Type: Journal    
DOI: 10.1080/00313020120034957     Document Type: Article

References (108)

1. Sarcoma growth factor from conditioned medium of virally transformed cells is composed of both type a and b transforming growth factors
2. Growth factors and cancer
3. The TGFβ family of growth and differentiation factors
4. Extracellular matrix-associated transforming growth factor-β: Role in cancer cell growth and invasion
5. TGFβ signal transduction
6. TGFβ in human platelets: Identification of a major storage site, purification and characterisation
7. 2, cDNA cloning and sequence analysis
8. Identification of another member of the TGF type β family
9. 1 mRNA in murine embryos and adult tissues
10. Complementary deoxyribonucleic acid cloning of a messenger ribonucleic acid encoding TGF-beta4 from chicken embryo chondrocytes
11. 5) mRNA in Xenopus laevis
12. Crystal structure of a transforming growth factor-beta2: An unusual fold for the superfamily
13. 1.2 heterodimers from bovine bone
14. The transforming growth factor-β system, a complex pattern of cross-reactive ligands and receptors
15. Latent transforming growth factor-β: Structural features and mechanisms of activation
16. 1 precursor with the insulin-like growth factor II/mannose 6-phosphate receptor
17. Cellular activation of latent transforming growth factor-β requires binding to the cation-independent mannose-6-phosphate/insulin-like growth factor type II receptor
18. 1: A mechanism for regulating pulmonary inflammation and fibrosis
19. 1 associates to fibroblast extracellular matrix via latent TGF binding protein
20. 1 in mice
21. Latent transforming growth factor-β in serum, a specific complex with alpha2-macroglobulin
22. Negative regulation of transforming growth factor-β by the proteoglycan decorin
23. Structure and expression of the membrane proteoglycan betaglycan, a component of the TGFβ receptor system
24. 1 activity by heparin and fucoidan
25. 1 clearance
26. Activation of the bone-derived latent TGFβ complex by isolated osteoclasts
27. 1 latency
28. Release and activation of platelet latent TGFβ in blood clots during dissolution with plasmin
29. 1 from extracellular matrix of cultured human epithelial and endothelial cells
30. The type I repeats of thrombospondin 1 activate latent transforming growth factor-β
31. Thrombospondin binds and activates the small and large forms of latent transforming growth factor-β in a chemically defined system
32. Thrombospondins selectively activate one of the two latent forms of transforming growth factor-β present in adrenocortical cell-conditioned medium
33. An activated form of transforming growth factor-β is produced by cocultures of endothelial cells and pericytes
34. Biosynthesis of the type I and type II TGFβ receptors-implications for complex formation
35. Mechanism of activation of the TGFβ receptor
36. Crystal structure of the cytoplasmic domain of the type I TGFβ receptor in the complex with FKBP12
37. The TGFβ receptor proteoglycan. Cell surface expression and ligand binding in the absence of glycosaminoglycan chains
38. The transforming growth factor-β family
39. Isoform-specific transforming growth factor-beta binding proteins with membrane attachments sensitive to phosphatidylinositol-specific phospholipase C
40. Primary structure of endoglin, an RGD-containing glycoprotein of human endothelial cells
41. Elevated expression of endoglin, a component of the TGFβ receptor complex, correlates with proliferation of tumour endothelial cells
42. Endoglin is an accessory protein that interacts with the signalling receptor complex of multiple members of the transforming growth factor-β superfamily
43. Endoglin is a component of the transforming growth factor-beta receptor system in human endothelial cells
44. Plasma levels of soluble CD105 correlate with metastasis in patients with breast cancer
45. Breast carcinoma: Vascular density determined using CD105 antibody correlates with tumour prognosis
46. Expression cloning of the TGFβ Type II Receptor, a functional transmembrane serine/threonine kinase
47. Biochemical evidence for the autophosphorylation and transphosphorylation of transforming growth factor beta receptor kinases
48. Ligand-independent activation of transforming growth factor (TGF) β signalling pathways by heteromeric cytoplasmic domains of the TGFβ receptors
49. TGFβ signals through a heteromeric protein kinase receptor complex
50. TGFβ signalling: Receptors, transducers, and Mad proteins
51. TGF signalling from cell membrane to nucleus through SMAD proteins
52. TGF-signalling and cancer: Structural and functional consequences of mutations in Smads
53. SMADs: Mediators and regulators of TGF-signalling
54. Specificity, diversity, and regulation in TGFβ superfamily signalling
55. Drosophila Mad binds to DNA and directly mediates activation of vestigial by Decapentaplegic
56. MADR2 is a substrate of the TGFbeta receptor and its phosphorylation is required for nuclear accumulation and signalling
57. Opposing BMP and EGF signalling pathways converge on the TGF-beta family mediator Smad 1
58. The MAD-related protein Smad 7 associates with the TGFβ receptor and functions as an antagonist of TGFβ signalling
59. Type β transforming growth factor: A functional regulator of cellular growth
60. Inhibition of endothelial cell regeneration by type-beta transforming growth factor from platelets
61. Transforming growth factor-β is an important immunomodulatory protein for human B lymphocytes
62. 1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRB binding domains
63. 1 arrest pathway
64. C-myc target genes involved in cell growth, apoptosis and metabolism
65. Repression of the CDK activator Cdc25A and cell cycle arrest by cytokine TGF-beta in cells lacking the CDK inhibitor p15
66. E2F and histone Deacetylase mediate transforming growth factor-β repression of cdc25A during keratinocyte cell cycle arrest
67. Growth inhibition by TGFβ linked to suppression of retinoblastoma protein phosphorylation
68. 1 in mammalian cells: Inhibition of cyclin E-dependent kinase by TGFβ
69. TGFβ inhibition of Cdk4 synthesis is linked to cell cycle arrest
70. kip1: A multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers
71. The cell biology of transforming growth factor-β
72. Transforming growth factor-β and its actions on cellular growth and differentiation
73. Transforming growth factor-β induction of type1 plasminogen activator inhibitor. Pericellular deposition and sensitivity to exogenous urokinase
74. Transforming growth factor-β: Possible role in carcinogenesis
75. Transforming growth factor-β
76. Genetic changes in the transforming growth factor-β (TGFβ) type II receptor gene in human gastric cancer cells: Correlation with sensitivity to growth inhibition by TGFβ
77. Inactivation of the type II TGFβ receptor in colon cancer cells with microsatellite instability
78. Colon cancer cells that are not growth inhibited by TGFβ lack functional type I and type II TGFβ receptors
79. Absence of TGFβ receptors and growth inhibitory responses in retinoblastoma cells
80. Missense mutations of the transforming growth factor-β type II receptor in human head and neck squamous carcinoma cells
81. Expression of transforming growth factor-β type II receptors in head and neck squamous cell carcinoma
82. Loss of receptors for transforming growth factor beta in human T-cell malignancies
83. Mutational analysis of the transforming growth factor-β receptor type II gene in human ovarian carcinoma
84. Structural alterations of transforming growth factor-β receptor genes in human cervical carcinoma
85. Human malignant thyroid tumours display reduced levels of transforming growth factor-β receptor type II messenger RNA and protein
86. Loss of expression of transforming growth factor beta type II receptor correlates with high tumour grade in human breast in situ and invasive carcinoma
87. Microsatellite instability and mutations of the transforming growth factor-β type II receptor gene in colorectal cancer
88. A transforming growth factor-β receptor type II gene mutation common in colon and gastric but rare in endometrial cancers with microsatellite instability
89. Reduced expression of transforming growth factor-β type I receptor contributes to the malignancy of human colon carcinoma cells
90. 1 in human prostate cancer cells
91. Transforming growth factor-β type I receptor kinase mutant associated with metastatic breast cancer
92. Type I transforming growth factor-β receptor maps to 9q22 and exhibits a polymorphism and a rare variant within a polyalanine tract
93. Regulated expression and growth inhibitory effects of transforming growth factor-β isoforms in mouse mammary gland development
94. Transforming growth factor-β and cell cycle regulation
95. Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients
96. 1 cyclin that binds Cdk2 and is aberrantly expressed in human cancers
97. Genetic events and the role of TGFβ in epithelial tumour progression
98. Transforming growth factor-β stimulates mammary adenocarcinoma cell invasion and metastatic potential
99. 1 enhances the invasiveness of human MDA-MB-231 breast cancer cells by up-regulating urokinase activity
100. DPC 4, a candidate tumour suppressor gene at human chromosome 18q21.1
101. Genetic alterations of the transforming growth factor-β receptor genes in pancreatic and biliary adenocarcinomas
102. Comparative mutations analysis of DPC 4 (Smad 4) in prostatic and colorectal carcinomas
103. DPC 4 gene in various tumour types
104. DPC 4, a candidate tumour suppressor gene is altered infrequently in head and neck squamous cell carcinoma
105. Infrequent DPC 4 gene mutation in esophageal cancer, gastric cancer and ulcerative colitis-associated neoplasms
106. MADR 2 maps to 18q21 and encodes a TGF-regulated MAD-related protein that is functionally mutated in colorectal carcinoma
107. A structural basis for mutational inactivation of the tumour suppressor Smad 4
108. Mutations increasing autoinhibition inactivate tumour suppressor Smad 2 and Smad 4